Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tutengcao granules for acute gouty arthritis (phase 2)
CTR20230031Phase 2Completed
- Sponsor
- Beijing Jiquan Biotechnology
- Start
- Jan 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Tutengcao Granules in acute gout flare, sponsored by Beijing Jiquan Biotechnology. Started Jan 2023; status: completed.
02
Drugs
Tutengcao Granules
03
Conditions
acute gout flare
Beyond the preview
Go deeper on CTR20230031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230031.